etoposide has been researched along with dithiothreitol in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fabisiak, JP; Kagan, VE; Ritov, VB | 1 |
| Berger, SA; Zhang, Y | 1 |
| Deweese, JE; Jacob, DA; Mercer, SL; Osheroff, N | 1 |
3 other study(ies) available for etoposide and dithiothreitol
| Article | Year |
|---|---|
Reversible thiol-dependent activation of ryanodine-sensitive Ca2+ release channel by etoposide (VP-16) phenoxyl radical.
Topics: Adenosine Triphosphate; Animals; Caffeine; Calcium; Calcium Signaling; Calcium-Transporting ATPases; Dithiothreitol; Enzyme Inhibitors; Etoposide; Free Radicals; Homeostasis; Ion Transport; Monophenol Monooxygenase; Muscle Proteins; Muscle, Skeletal; Oxidation-Reduction; Oxidative Stress; Phenols; Rabbits; Ruthenium Red; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum; Sulfhydryl Reagents | 2000 |
Increased calcium influx and ribosomal content correlate with resistance to endoplasmic reticulum stress-induced cell death in mutant leukemia cell lines.
Topics: Anti-Bacterial Agents; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Area Under Curve; Calcium; Cell Death; Cell Line, Tumor; Cycloheximide; Dithiothreitol; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Econazole; Endoplasmic Reticulum; Endoplasmic Reticulum Chaperone BiP; Etoposide; Fas Ligand Protein; Flow Cytometry; HL-60 Cells; Humans; Leukemia; Membrane Glycoproteins; Oligonucleotide Array Sequence Analysis; Phenotype; Ribosomes; Thapsigargin; Time Factors; Tunicamycin | 2004 |
Etoposide quinone is a redox-dependent topoisomerase II poison.
Topics: Antigens, Neoplasm; Benzoquinones; Catechols; Dithiothreitol; DNA Adducts; DNA Damage; DNA Topoisomerases, Type II; DNA-Binding Proteins; Enzyme Stability; Etoposide; Humans; Leukemia, Myeloid, Acute; Oxidation-Reduction; Reducing Agents | 2011 |